Risk minimization measures
| Scientific Name | Brand name | Approval Date | Last Update | Details |
|---|---|---|---|---|
| Rivaroxaban | Banoriv | Details | ||
| Agomelatine | Valdoxan | Details | ||
| Onasemnogene Abeparvovec | Zolgensma | Details | ||
| Insulin Glargine 100 units/mL + Lixisenatide | Soliqua | Details | ||
| Enoxaparin Sodium | Clexane | Details | ||
| Atezolizumab | Tecentriq | Details | ||
| Teriflunomide | Axyla | Details | ||
| Tenofovir | Viread | Details | ||
| Emicizumab | Hemlibra | Details | ||
| Rivaroxaban | Xarelto | Details |
